Dark

GSK
GSK plc
stock NYSE ADR

At Close

May 16, 2025 3:59:30 PM EDT

37.67USD+0.253%(+0.10)7,222,246

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 16, 2025 9:28:30 AM EDT

37.03USD-1.437%(-0.54)34,295

After-hours

May 16, 2025 4:41:30 PM EDT

37.64USD-0.066%(-0.03)28,009

OverviewOptionsHistoricalExchangesShortsNews

Jan 23, 2022

03:10PM EST Activist Investor Nelson Peltz's Fund Buys Stake In Unilever: FT Benzinga

Jan 21, 2022

06:55AM EST Indian Antitrust Authority Has Approved GlaxoSmithKline's Purchase Of Asia Private Benzinga

Jan 19, 2022

07:24AM EST GlaxoSmithKline Said Earlier Wednesday that Hal Barron will Leave his position as Chief Scientific Officer in August to Run Start-up Biotech Company; Tony Wood Named New CSO Benzinga

Jan 18, 2022

02:20PM EST GlaxoSmithKline Option Alert: Feb 4 $48 Calls Sweep (23) near the Ask: 1042 @ $0.45 vs 19 OI; Earnings 2/9 Before Open Ref=$46.67 Benzinga

06:57AM EST UPDATE: 23andMe Announces GSK Extends Exclusive Target Discovery Period To Jul. 23; 23andMe To Receive $50M One-Time Payment Benzinga

06:56AM EST 23andMe Announces Extension Of GSK Collaboration Benzinga

Jan 15, 2022

02:17PM EST GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit Benzinga

Jan 14, 2022

12:22PM EST WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge Benzinga

Jan 13, 2022

11:48AM EST GSK And Vir Submit Emergency Use Authorization Application To FDA For Intramuscular Administration Of Sotrovimab For The Early Treatment Of COVID-19 Benzinga

09:03AM EST If authorized, would provide the option for intramuscular administration of sotrovimab, in addition to currently authorized intravenous administration GlobeNewswire Inc

Jan 11, 2022

10:16AM EST EU Drug Regulators Say GlaxoSmithKline's Strovimab Appears To Be The Only EU Approved Monoclonal Antibody That Neutralizes The New Variant Benzinga

07:22AM EST GSK And Vir Biotechnology Announce United States Government Agreement To Purchase 600K Additional doses Of Sotrovimab, Authorized For Early Treatment Of COVID-19 Benzinga

07:13AM EST 600,000 additional doses to be supplied to the US government for distribution in Q1 2022,enabling further access to sotrovimab nationwide GlobeNewswire Inc

Jan 10, 2022

05:25AM EST CureVac Outlines Upcoming Catalysts For Vaccine Programs Benzinga

Jan 7, 2022

01:07PM EST French Regulator Says It Allows Early Access To GlaxoSmithKline's New Xevudy COVID-19 Treatment Benzinga

01:02PM EST 908 Devices Reports GlaxoSmithKline Purchased An Added REBEL Cell Culture Media Analyzer, No Terms Disclosed Benzinga

Jan 6, 2022

02:23PM EST GSK Announces Additional Purchase Agreements With Government Of Canada For COVID-19 Monoclonal Antibody Therapy, Sotrovimab Benzinga

Dec 23, 2021

03:15PM EST GlaxoSmithKline's Jemperli As Anti-PD-1 Therapy For Recurrent, Advanced Endometrial Cancer Approved In Canada Benzinga

07:51AM EST GlaxoSmithKline's RECOVERY Trial To Investigate Sotrovimab For Possible Treatment For Patients Hospitalized With COVID-19 Benzinga

Dec 22, 2021

04:13PM EST Epizyme 8-K Shows Co. Received Written Notice From Glaxo Group GSK Elected To Terminate Collab, License Deal With Epizyme Benzinga

03:26PM EST 'In @WHCOVIDResponse briefing, Zients gives update on supply in what he calls the nation's medicine cabinet for #covid19. In Jan.: 265K courses of Pfizer drug, 3M of Merck drug (if authorized), 500K+ of AZN preventive antibody, 300K of Vir/GSK antibody' Benzinga

Dec 21, 2021

04:02PM EST Ligand And GSK Expand Global Collaboration And License Agreement; Ligand To Receive An Upfront Payment Of $10M And Is Eligible For Development And Regulatory Milestones Up To $67.5M Benzinga

08:12AM EST The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail Benzinga

06:42AM EST Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative Option Benzinga

Dec 20, 2021

03:40PM EST FDA Approves GlaxoSmithKline's Injectable Treatment for HIV Pre-Exposure Prevention Benzinga

Dec 17, 2021

08:19AM EST GlaxoSmithKline Confirms Earlier Report Co's Xevudy Granted Marketing Authorization By European Commission For Early Treatment Of COVID-19 Benzinga

08:17AM EST Xevudy (Sotrovimab) Granted Marketing Authorization by the GlobeNewswire Inc

07:49AM EST GlaxoSmithKline Reports Xevudy Approved In Europe To Treat COVID-19 Benzinga

Dec 15, 2021

11:13AM EST Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back Benzinga

08:03AM EST The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO Benzinga

04:59AM EST Sanofi, GlaxoSmithKline Said They Expect Data from Late-stage Clinical Trials of its Booster Dose of Their Covid-19 Vaccine Candidate in Q1 2022 vs Late 2021 Benzinga

Dec 8, 2021

10:16AM EST GlaxoSmithKline Granted FDA Approval For BLENREP Benzinga

Dec 7, 2021

10:03AM EST UK's Medicines And Healthcare Products Regulatory Agency Approves XEVUDY, GlaxoSmithKline And Vir Biotechnology's Monoclonal Antibody Treatment For Patients With COVID-19 Benzinga

08:26AM EST The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Dar Benzinga

07:49AM EST Medicago, GSK's Plant-Based COVID-19 Vaccine Candidate Hits 75% Efficacy Against Delta Strain Benzinga

07:13AM EST Medicago And GSK Announce Positive Phase 3 Efficacy And Safety Results For Adjuvanted Plant-Based COVID-19 Vaccine Candidate; Says Primary And Secondary Endpoints For Which Data Are Available Were Met, 75.3% Efficacy Benzinga

05:23AM EST GlaxoSmithKline, Vir Biotechnology Announced Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutations in the Spike Protein of the Omicron SARS-CoV-2 Variant Benzinga

03:49AM EST New preclinical findings generated through in vitro testing of sotrovimab againstthe complete pseudo-virus updated to bioRxiv GlobeNewswire Inc

02:20AM EST GSK, Vir Biotechnology Announce Preclinical Findings Generated Through In Vitro Testing Of Sotrovimab RTTNews

Dec 2, 2021

01:18PM EST GlaxoSmithKline Says Will Continue To Supply Adjuvant (AS01E) To Ocugen Partner Bharat Bio; Product Transfer Also Under Way With Bharat Benzinga

09:49AM EST Former FDA Commissioner Scott Gottlieb Retweets Earlier Press Release Highlighting Vir Biotech/GlaxoSmithKline's Antibody Retains Activity vs Omicron Mutations In Lab Tests Benzinga

07:51AM EST The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance Benzinga

05:25AM EST GlaxoSmithKline, Vir Said Sotrovimab Retains its Activity vs Omicron Variant Benzinga

02:07AM EST Preclinical data demonstrate sotrovimab, authorized in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron GlobeNewswire Inc

Dec 1, 2021

06:36AM EST Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition Benzinga

Nov 23, 2021

02:16PM EST Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst Benzinga

08:10AM EST The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug Benzinga

07:14AM EST GlaxoSmithKline Pens $1B Pact For NASH Candidate With Arrowhead Benzinga

Nov 22, 2021

04:02PM EST Arrowhead Pharmaceuticals Enters Exclusive License Agreement With GSK For ARO-HSD; Arrowhead To Receive $120M Upfront Payment For Phase 1/2 Program For NASH Benzinga

Nov 18, 2021

08:38AM EST GSK Showcases Progress From The DREAMM Clinical Trial Program In Multiple Myeloma At The 2021 ASH Annual Meeting Benzinga

07:55AM EST The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings Benzinga

Nov 17, 2021

09:08AM EST Robitussin Teams Up with Tony Award-Winning Actress, Adrienne Warren, to Help PR Newswire

07:53AM EST The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment Benzinga

06:44AM EST GSK And Vir Biotechnology Announce $1B In United States Government Agreements To Purchase Sotrovimab COVID-19 Treatment Benzinga

06:43AM EST US government contracts for approximately $1 billion1 (USD) now in place to purchase sotrovimab,further expanding access nationwide GlobeNewswire Inc

Nov 15, 2021

11:21AM EST TUMS(r) Provides #TUMSworthy Holiday Hacks for Heartburn Inducing Moments this PR Newswire

Nov 12, 2021

09:42AM EST GSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19 Benzinga

07:15AM EST GlaxoSmithKline, Vir Biotech Report Primary Endpoint Was Met In COMET-TAIL Phase 3 Trial In Candidate For Treatment Of Intramuscular Admin. Of Sotrovimab Benzinga

07:12AM EST GlaxoSmithKline Reports Primary Endpoint Was Met In COMET-TAIL Phase 3 Trial In Candidate For Treatment Of Intramuscular Admin. Of Sotrovimab Benzinga

07:10AM EST COMET-TAIL Phase 3 data demonstrated that intramuscular administration of sotrovimab wasnon-inferior and offered similar efficacy to intravenous administration for high-risk populations GlobeNewswire Inc

Nov 8, 2021

11:37AM EST GlaxoSmithKline Spotlights Encouraging Data For Anemia Drug Benzinga

Nov 5, 2021

03:48PM EDT GlaxoSmithKline Reports Phase 3 Efficacy, Safety Data For Daprodustat In Patients With Anaemia Due To Kidney Disease Benzinga

03:47PM EDT GSK announces positive Phase III efficacy and safety data for daprodustat in PR Newswire

10:07AM EDT Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021 Benzinga

09:43AM EDT The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill Benzinga

09:37AM EDT Barclays Upgrades GlaxoSmithKline to Equal-Weight Benzinga

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 28, 2021

08:26AM EDT The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug Benzinga

Oct 27, 2021

01:12PM EDT GlaxoSmithKline Drops Research On Otilimab In COVID-19 Benzinga

09:32AM EDT Glaxo Reports Double-Digit Growth In Q3 Pharma, Vaccine Sales, Updates FY21 Guidance Benzinga

07:10AM EDT GlaxoSmithKline Q3 Adj. EPS 0.366 Pence; Raises FY21 Guidance, Reaffirms FY22 Guidance Benzinga

03:43AM EDT Earnings Scheduled For October 27, 2021 Benzinga

Oct 26, 2021

08:51AM EDT GSK's Theraflu Launches Rest & Recover Fund To Help More Americans Take Sick Day When Needed RTTNews

08:47AM EDT Theraflu Launches the Rest & Recover Fund to Help More Americans Take a Sick PR Newswire

08:36AM EDT The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children Benzinga

08:32AM EDT Berkeley Lights, Inc. (Nasdaq: BLI), a leader indigital cellbiology,today announcedthatGlaxoSmithKline (NYSE:GSK)has purchasedan additionalBeacon Optofluidic system to expand its antibody therapeutics capacity. The new Beacon system will leverage Berkeley Lights Opto Plasma B Discovery workflow to perform functional analysis, further accelerating the lead selection process. GlobeNewswire Inc

08:30AM EDT The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children Benzinga

Oct 18, 2021

01:15PM EDT GlaxoSmithKline To Present On Its Renal Care Products At American Society Of Nephrology Kidney Week Oct. 22 Benzinga

Oct 14, 2021

10:32AM EDT 'Glaxo Board and Activist Hedge Fund Bluebell Spar in New Letters' -Bloomberg Benzinga

Oct 12, 2021

10:25AM EDT Winners and Losers of Rising Energy Prices Benzinga

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Oct 11, 2021

01:33PM EDT AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial Benzinga

Oct 7, 2021

09:06AM EDT IIROC Trade Resumption - GSK PR Newswire

Oct 6, 2021

01:20PM EDT IIROC Trading Halt - GSK PR Newswire

11:51AM EDT World Health Organization Recommends Broad Deployment Of GlaxoSmithKline Malaria Vaccine In Subsaharan Africa, Other At-Risk Regions Benzinga

Oct 4, 2021

12:47PM EDT GlaxoSmithKline Said Monday It Signed A Deal To Supply 10K Doses Of Its COVID-19 Monoclonal Antibody Therapy To Canadian Government Benzinga

10:21AM EDT Tesla and Merck Give Investors Some Hope Benzinga

Oct 1, 2021

08:29AM EDT Medicago To Launch Clinical Trials For COVID-19 Vaccine Candidate With GSK's Pandemic Adjuvant In Japan; Candidate Has Now Completed Enrollment Of Its Phase 2/3 Clinical Trials Benzinga

Sep 30, 2021

03:27PM EDT GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact Benzinga

07:43AM EDT The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug Benzinga

Sep 29, 2021

08:44AM EDT ViiV Healthcare's Dovato Combo Regime Shows Encouraging Long Term Data In HIV Patients Benzinga

Sep 28, 2021

08:52AM EDT Sensodyne(r) Repair and Protect with Deep Repair is Proud to Deliver a Minty & PR Newswire

08:18AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive Benzinga

08:16AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments Benzinga

07:53AM EDT Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know Benzinga

06:46AM EDT ViiV Healthcare: FDA Grants Priority Review To Cabotegravir NDA For Prevention Of HIV RTTNews

06:40AM EDT FDA grants Priority Review to ViiV Healthcare's New Drug Application for cabotegravir long-acting for prevention of HIV Business Wire

Sep 27, 2021

04:00PM EDT Glaxo - Vir Biotech's COVID Treatment Approved In Japan Benzinga

12:01PM EDT Analyst Upgrades Sanofi On COVID-19 Vaccine Optimism Benzinga

Sep 22, 2021

12:07PM EDT GlaxoSmithKline Spokesperson Says Bluebell Capital Partners Has Sent Letter To Chairman; Says Points Set Out In Letter Are Not New, Says Has Already Made Clear Co Is Addressing Them Benzinga

10:35AM EDT Green Hygienics Holdings To Raise $100M Via Green Bond Offering Benzinga

Sep 15, 2021

02:58PM EDT GlaxoSmithKline's Nucala Approved In Canada As First, Only Biologic Treatment For Adults With Hypereosinophilic Syndrome Benzinga

Sep 14, 2021

08:34AM EDT Withdraws Headline: GSK, Vir Biotechnology Sign Joint Procurement Deal With EU To Supply 220,000 Doses Of Sotrovimab RTTNews

07:53AM EDT GSK, Vir Biotechnology Sign Joint Procurement Deal With EU To Supply 220,000 Doses Of Sotrovimab RTTNews

Sep 3, 2021

08:13AM EDT White House Commits $3B To Boost COVID-19 Vaccine Supply Chain: Report Benzinga

Sep 2, 2021

04:08PM EDT Can Vaccine Help In Long Term COVID-19 Symptoms? UK Study Gives Encouraging Answer Benzinga

Aug 31, 2021

07:12AM EDT Glaxo, SK Bioscience Start COVID-19 Vaccine Trial Against AstraZeneca Shot Benzinga

05:05AM EDT SK Bioscience and GSK Initiate Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate Benzinga

Aug 26, 2021

04:21PM EDT EU Says Without EMA Approval COVID-19 Boosters May Face Higher Legal Risks: Reuters Benzinga

Aug 24, 2021

07:47AM EDT Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial Benzinga

Aug 23, 2021

12:05PM EDT Vir Biotech-GSK's COVID-19 Treatment Wins Provisional Approval In Australia Benzinga

Aug 19, 2021

10:57AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

Aug 18, 2021

01:32PM EDT GlaxoSmithKline PLC Looks To Continue To Trade Above Its Annual-High Share Price Today Benzinga

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

07:00AM EDT AnaptysBio-Generated Antibody Scores Second FDA Approval For Solid Tumor Indication Benzinga

Aug 17, 2021

04:34PM EDT AnaptysBioFDA Grants Accelerated Approval Of GSK's JEMPERLI, Which Was Generated By AnaptysBio; Co. Has Earned $20M Milestone Payment As A Result Benzinga

04:15PM EDT GlaxoSmithKline Reports Received FDA Accelerated Approval For Jemperli For Adult Patients With Mismatch Repair-Deficient Recurrent, Advanced Solid Tumors Benzinga

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 16, 2021

07:12AM EDT Curevac And GSK Announce Second-Generation MRNA COVID-19 Vaccine Candidate, Cv2Cov, Demonstrates Improved Immune Response And Protection In Preclinical Study Benzinga

Aug 13, 2021

09:09AM EDT Do mRNA COVID-19 Vaccines Cause Skin Or Kidney Disorders? EMA Investigates Possible Links Benzinga

Aug 4, 2021

09:06AM EDT Natera Reports Use Of Signatera As Companion Diagnostic In GlaxoSmithKline's Phase 3 ZEST Trial For Niraparib In Early-Stage Breast Cancer Benzinga

Aug 2, 2021

01:45PM EDT GlaxoSmithKline Files US Application For Approval Of Its MMR Vaccine Benzinga

12:33PM EDT Cannabis Movers & Shakers: BioHarvest Sciences, Green Hygienics, Realm of Caring, Media Central Corp, Al Harrington's Viola Benzinga

10:09AM EDT Barron's Latest Picks And Pans: American Express, GE, GlaxoSmithKline, Intel And More Benzinga

Jul 30, 2021

07:51AM EDT GlaxoSmithKline's Scores FDA Approval For First IL-5 Inhibitor In Nasal Polyps Benzinga

Jul 29, 2021

07:42PM EDT GSK Announces FDA Approval For Nucala For Use In Adults With Chronic Rhinosinusitis With Nasal Polyps RTTNews

06:03PM EDT GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps Business Wire

03:58PM EDT Avoid These 7 Stocks in Retirement Like the Plague Benzinga

02:18PM EDT GlaxoSmithKline Announces FDA Approval For Nucala (Mepolizumab) For Use In Adults With Chronic Rhinosinusitis With Nasal Polyps Benzinga

Jul 28, 2021

09:11AM EDT Vaccine Demand Boosts GlaxoSmithKline's Q2 Sales, Earnings; Maintains FY21 Guidance Benzinga

07:13AM EDT European Commission To Procure 220K Doses Of Glaxo-Vir Biotech's COVID-19 Antibody Benzinga

07:05AM EDT Glaxosmithkline Q2 Sales Rose 6% To 8.1B, Adj. EPS Benzinga

06:26AM EDT GSK And Vir Biotechnology Announce Joint Procurement Agreement With European Commission For Sotrovimab COVID-19 Treatment To Supply Up To 220K Doses Benzinga

06:20AM EDT GSK and Vir Biotechnology Announce Joint Procurement Agreement GlobeNewswire Inc

06:08AM EDT EU Commission Says Signed Procurement Contract With GlaxoSmithKline for Supply of Monoclonal Antibody Therapy Against Covid-19 Benzinga

04:27AM EDT Earnings Scheduled For July 28, 2021 Benzinga

Jul 26, 2021

09:41AM EDT GlaxoSmithKline : Shingrix Approved In US For Prevention Of Shingles In Immunocompromised Adults RTTNews

09:40AM EDT GlaxoSmithKline Says Co's Shingrix Approved In U.S. For Prevention Of Shingles In Immunocompromised Adults Benzinga

09:39AM EDT Shingrix approved in the US for prevention of shingles in immunocompromised PR Newswire

Jul 22, 2021

09:52AM EDT GlaxoSmithKline Names Brian McNamara CEO Designate Of New Consumer Healthcare Co. Benzinga

Jul 20, 2021

02:32PM EDT EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine Benzinga

Jul 16, 2021

09:49AM EDT GlaxoSmithKline's Anemia Candidate Shows Promise In Late-Stage Studies Benzinga

07:34AM EDT GSK To Sell One-Third Of Its UK R&D Site For 400M Benzinga

07:01AM EDT GlaxoSmithKline Reports Results For Daprodustat Phase 3 Headline Trial: Study Met Primary Efficacy Endpoint, Co. Will Continue Data Analysis In Phase 3 ASCEND Trial Benzinga

Jul 11, 2021

05:10PM EDT The Past Week's Notable Insider Buys Include Krispy Kreme, Biotechs, SPACs And More Benzinga

Jul 8, 2021

09:56AM EDT A Look Into GlaxoSmithKline's Price Over Earnings Benzinga

09:19AM EDT Sanofi, GSK Get Nod For Late-Stage COVID-19 Vaccine Trial In India Benzinga

Jul 7, 2021

04:07PM EDT Codexis Says Earns Milestone Payment From GlaxoSmithKline Benzinga

01:45PM EDT COVID-19 Vaccine-Induced Blood Clots Probably Linked To Amino Acids, Study Shows: WSJ Benzinga

01:26AM EDT Nvidia Launches Supercomputer To Help Advance Fields Of Digital Biology, Genomics Benzinga

01:21AM EDT Nvidia UK Supercomputer...What You Need To Know Benzinga

Jul 2, 2021

11:49AM EDT GlaxoSmithKline's Board Backs CEO Walmsley After Elliott's Letter For Management Shakeup Benzinga

08:26AM EDT Alector Shares Jump On $2.2B Immuno-Neurology Development Pact With GSK Benzinga

07:39AM EDT Alector and GSK announce global collaboration in immuno-neurology GlobeNewswire Inc

Jul 1, 2021

03:05PM EDT Activist Fund Elliott Management Wants GlaxoSmithKline Board Shakeup For 'Years Of Under Management' Benzinga

Jun 30, 2021

12:34PM EDT Singapore's Health Sciences Authority Grants Interim Authorization For GlaxoSmithKline, Vir Biotech's Sotrovimab For COVID-19 Benzinga

Jun 29, 2021

03:28PM EDT EC Selects Antibody Therapies, Arthritis Drug As Preferred COVID-19 Meds: Reuters Benzinga

01:05PM EDT TUMS(r) Fuels the Autoburn, a Road Trip to America's Spiciest Destinations, PR Newswire

Jun 28, 2021

10:58AM EDT AstraZeneca COVID-19 Vaccine Shows Higher Immune Response With Longer Gap, Third Booster Dose Benzinga

Jun 25, 2021

03:01PM EDT GlaxoSmithKline Shares Earlier Saw Volatility Following Report Co. Hired Goldman, Citi To Consider A Spinoff Of Its Consumer Unit Benzinga

Jun 23, 2021

07:43AM EDT A Look Into GlaxoSmithKline's Debt Benzinga

06:07AM EDT GlaxoSmithKline Announces Sales Ambition Of More Than 33B (CER) By 2031 Benzinga

06:05AM EDT GlaxoSmithKline Sees Sales Growth More Than 5% And Adjusted Operating Profit Growth More Than 10% CAGR 2021-26; Cash Generated From Operations Expected To Exceed 10B By 2026 Benzinga

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

07:01AM EDT Dual-Antibody Cocktail Shows Effectiveness In COVID-19 Animal Models: Reuters Benzinga

06:29AM EDT GSK- Pfizer's ViiV To Develop 'Ultra-Long-Acting' HIV Drugs With $215M Halozyme Deal Benzinga

05:12AM EDT ViiV Healthcare, Halozyme Enter Global Collaboration and License Agreement for ENHANZE Drug Delivery Technology to Enable Development of Ultra-long-acting Medicines for HIV Benzinga

02:22AM EDT ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE(r) drug delivery technology to enable development of "ultra long-acting" medicines for HIV Business Wire

02:21AM EDT ViiV Healthcare, Halozyme Sign Global Collaboration And License Deal For ENHANZE Drug Delivery Technology RTTNews

02:19AM EDT for ENHANZE(r) drug delivery technology to enable development of "ultra-long-acting" medicines for HIV PR Newswire

Jun 21, 2021

12:35PM EDT GlaxoSmithKline CEO Struggling To Get Key Shareholders In Her Favor Amid Pressure From Hedge Fund Activist Elliott Management Benzinga

11:41AM EDT GSK - Vir Biotech's Sotrovimab Reduces Hospitalization, Risk Of Death In Adult COVID-19 Patients Benzinga

07:10AM EDT GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for Sotrovimab Benzinga

07:06AM EDT Analysis of final Day 29 data from COMET-ICE confirms sotrovimab significantly reduceshospitalization and risk of death in adults with mild-to-moderate COVID-19 who are at high riskof progression to severe disease GlobeNewswire Inc

Jun 17, 2021

05:07AM EDT Tesla-Backed CureVac Plunges On Underwhelming COVID-19 Vaccine Efficacy Data Benzinga

Jun 14, 2021

07:10AM EDT iTeos Therapeutics And GSK Announce Development And Commercialisation Collaboration For EOS-448, An Anti-TIGIT Monoclonal Antibody, Enabling Novel Next-generation Immuno-oncology Combinations Benzinga

07:00AM EDT GSK And Iteos Announce Collaboration For Eos-448; Eos-448 Is Currently In Phase I For Advanced Solid Tumours With A Randomised Pd-1 Combination Study Planned For 2022 Benzinga

07:00AM EDT iTeos Therapeutics and GSK announce development and GlobeNewswire Inc

Jun 8, 2021

10:38AM EDT VBI Vaccines' Brain Cancer Immunotherapy Gets FDA Fast Track Review; Announces Updated Tumor Response, Overall Survival Data Benzinga

Jun 3, 2021

04:13PM EDT 'Halftime Report' Traders Weigh In On GlaxoSmithKline, Snowflake And More Benzinga

Jun 2, 2021

09:45AM EDT Kuwait Approved Sotrovimab Treatment For COVID-19 Benzinga

Jun 1, 2021

02:55PM EDT Activist Hedge Fund Elliott Questions GSK CEO Walmsley's Leadership: Mail on Sunday Benzinga

10:10AM EDT A Look Into GlaxoSmithKline's Price Over Earnings Benzinga

09:05AM EDT Immutep, Merck Germany Team Up for Eftilagimod/Bintrafusp Combo Trial In Solid Tumors Benzinga

08:11AM EDT CureVac's COVID-19 Vaccine Is Safe, But Efficacy Not Yet Disclosed Benzinga

May 27, 2021

01:16PM EDT Activist Hedge Fund Elliott Management Backs Away from Forced GlaxoSmithKline's Vaccines, Pharma Business Sale: The Times Benzinga

09:52AM EDT GSK and Vir Biotechnology Late Wednesday Announced Sotrovimab Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients Benzinga

08:24AM EDT The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs Benzinga

08:10AM EDT Vir Biotech Stock Jumps After FDA Emergency Use Approval COVID-19 Antibody Drug Benzinga

08:07AM EDT Sanofi, GSK Start Final Testing Phase Of COVID-19 Vaccine Benzinga

May 26, 2021

08:43PM EDT Xencor: Sotrovimab Receives FDA EUA For Treatment Of Mild-to-moderate COVID-19 In Adults And Pediatric Patients RTTNews

06:58PM EDT Treatment with sotrovimab resulted in an 85% reduction in the risk of hospitalization or death in high-riskadult outpatients compared to placebo, based on interim results from Phase 3 COMET-ICE trial GlobeNewswire Inc

05:32PM EDT GlaxoSmithKline Shares Tick Higher; Traders Circulate FDA Letter In Response To Co Issuing Emergency Use Authorization For Sotrovimab For Treatment Of Mild-To-Moderate Coronavirus Disease Benzinga

12:21PM EDT FDA May Not Review New COVID-19 Vaccine Emergency Use Requests Benzinga

May 21, 2021

11:56AM EDT GlaxoSmithKline - Vir Biotech's Antibody COVID-19 Treatment Wins CHMP's Positive Scientific Opinion Benzinga

09:30AM EDT Vir Biotech, On Its Early Treatment For COVID-19 Candidate, Says 'Discussions with global regulators regarding authorizations in additional countries continue to advance' Benzinga

07:49AM EDT EMA Says Concluded Sotrovimab Can Be Used To Treat COVID-19 In Adults And Adolescents Not Requiring Supplemental Oxygen Therapy And Risk Of Progressing To Severe COVID-19; Says A Rolling Review Of Sotrovimab, Which Started On 7 May, Is Ongoing Benzinga

May 20, 2021

10:06AM EDT Innoviva To Buy GSK's Stake In Innoviva, Constituting 32 Mln Shares Or 32% Of Outstanding Stock, At $12.25/shr RTTNews

09:41AM EDT Innoviva Announces Strategic Repurchase Of GSK's Equity Stake Benzinga

08:45AM EDT Cramer Shares His Thoughts On Marvell, MicroVision, More Benzinga

May 18, 2021

09:04AM EDT GSK:Advil Teams Up With Comedian Anderson To Inspire People Everywhere To Reclaim Life' Possibilities After Vaccination RTTNews

09:03AM EDT Advil Teams Up with Actor and Comedian Anthony Anderson to Inspire People PR Newswire

07:44AM EDT The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO Benzinga

06:30AM EDT GlaxoSmithKline-Medicago's COVID-19 Vaccine Candidate Elicit Strong Immune Response Benzinga

01:04AM EDT Medicago, GSK Announce Positive Interim Phase 2 Results For Adjuvanted COVID-19 Vaccine Candidate RTTNews

May 17, 2021

10:20AM EDT GlaxoSmithKline Option Alert: Jun 18 $41 Calls Sweep (4) near the Ask: 1563 @ $0.281 vs 40 OI; Ref=$39.585 Benzinga

07:07AM EDT Sanofi-GSK's COVID-19 Vaccine Candidate Reports Success In Mid-Stage Study Benzinga

May 12, 2021

04:19PM EDT Fulcrum Therapeutics, Evofem Biosciences Drug Candidates Receive FDA Fast Track Designation Benzinga

10:16AM EDT VBI Vaccines' Three-Antigen HBV Vaccine Candidate Trial Data Published In Lancet Infectious Diseases Benzinga

May 10, 2021

02:42PM EDT FDA To Hold AdCom Meeting For Expanding Use COVID-19 Vaccine In Children Benzinga

May 7, 2021

07:41AM EDT GSK and Vir Biotechnology Earlier Announced The Start Of The EMA Rolling Review of VIR-7831 For The Early Treatment Of COVID-19 Benzinga

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

05:54AM EDT Rolling review will evaluate sotrovimab in adults and adolescents with COVID-19 who do not require oxygen supplementation and who are at risk of progressing to severe COVID-19 GlobeNewswire Inc

May 6, 2021

07:20AM EDT Biden Administration Backs Waiving IP Protections For COVID-19 Vaccines, Pharma Industry Rebukes Move Benzinga

May 4, 2021

08:17AM EDT Viiv Healthcare Initiates Rolling Submission Of New Drug Application With US FDA For Long-Acting Cabotegravir For Prevention Of HIV Benzinga

May 3, 2021

01:08PM EDT Novavax Next In List To Start Testing Its COVID-19 Shot In Adolescents Benzinga

09:39AM EDT GSK : New Study Reveals Early Morning Experiences And Challenges Of Those With Arthritis Joint Pain RTTNews

09:37AM EDT Voltaren Arthritis Pain Gel Empowers Early Morning Risers Living with PR Newswire

Apr 30, 2021

11:14AM EDT Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days Benzinga

Apr 29, 2021

02:50PM EDT Pfizer-BioNTech Bullish On COVID-19 Vaccine Trial Results In Infants By September: Reuters Benzinga

Apr 28, 2021

01:29PM EDT Sanofi Shares Rise On Q1 Sales Boosted By Dupixent Franchise; Plans To Restart Haemophilia Study With Fitusiran Benzinga

10:04AM EDT GlaxoSmithKline Q1 Profit, Sales Decline As COVID-19 Vaccination Delay Other Treatments; Backs 2021 Outlook Benzinga

07:11AM EDT GlaxoSmithKline Plc Reports Q1 Adj Share Fell 33% To 22.9 Pence Benzinga

Apr 27, 2021

08:21AM EDT US To Share Up To 60M AstraZeneca COVID-19 Vaccine Doses Benzinga

Apr 26, 2021

09:18AM EDT Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine Benzinga

Apr 23, 2021

03:03PM EDT GlaxoSmithKline's Immunotherapy For Endometrial Cancer Wins FDA Approval Benzinga

10:06AM EDT EU Approves GlaxoSmithKline's Jemperli (dostarlimab-gxly) Benzinga

08:14AM EDT GlaxoSmithKline Partner Medicago Says Health Canada Received For Review First Portion Of Medicago's Plant-derived COVID-19 Vaccine Candidate Rolling Submission On April 19 Benzinga

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Apr 22, 2021

04:36PM EDT GlaxoSmithKline Says FDA Approved JEMPERLI, A Programmed Death Receptor-1 Blocking Antibody RTTNews

04:34PM EDT GlaxoSmithKline Says FDA Grants Accelerated Approval For Co's JEMPERLI For Women With Recurrent Or Advanced dMMR Endometrial Cancer Benzinga

04:34PM EDT FDA grants accelerated approval for GSK's JEMPERLI (dostarlimab-gxly) for women PR Newswire

02:13PM EDT GlaxoSmithKline's Immunotherapy For Endometrial Cancer Wins FDA Approval Benzinga

01:10PM EDT FDA Approves GlaxoSmithKline's Immunotherapy For Endometrial Cancer With Specific Biomarker Benzinga

Apr 19, 2021

09:10AM EDT GSK Consumer Healthcare Announces Commitment To Reducing The Plastic In Over 80 Mln Advil Bottles By 20% RTTNews

09:08AM EDT Advil to Reduce Plastic in Over 80 Million Bottles by 20% with New Sustainable PR Newswire

Apr 15, 2021

09:52AM EDT GSK, Vir Biotechnology Announce European Medicines Agency Review Of Dual-Action Monoclonal Antibody VIR-7831 For Early Treatment of COVID-19 Benzinga

09:51AM EDT GSK and Vir Biotechnology Announce EMA Review of Dual-Action GlobeNewswire Inc

09:11AM EDT Viome Appoints Emmanuel Hanon As Global Head Of Research And Development RTTNews

09:01AM EDT GSK Global Head of Vaccine Research and Development Joins Viome To Tackle PR Newswire

08:18AM EDT Benzinga Pro's Top 5 Stocks To Watch For Thursday, Apr. 15, 2021: DELL, AEO, GSK, UNH, INO Benzinga

08:09AM EDT EMA Says Reviewing Currently Available Data On Use Of Monoclonal Antibody VIT-7831 In Treatment Of Patients With COVID-19 Benzinga

07:26AM EDT Hedge Fund Elliott Builds Up Multibillion-Pound Stake In GSK Benzinga

Apr 14, 2021

05:00PM EDT GSK Provides Update On Its Feladilimab And Its Investigational Inducible T Cell Co-Stimulatory Agonist Benzinga

09:13AM EDT UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots Benzinga

Apr 12, 2021

02:43PM EDT South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report Benzinga

11:18AM EDT Zentalis's Early WEE1 Inhibitor Data Shows 'Exceptional' Response In Solid Tumor Study, Plans Combination Trials Benzinga

07:06AM EDT Zentalis Pharmaceuticals Enters into Clinical Collaboration and Supply Agreement with GlaxoSmithKline to Evaluate its Oral WEE1 Inhibitor, ZN-c3, in Combination with Niraparib, a PARP Inhibitor Benzinga

Apr 9, 2021

09:34AM EDT BioSig Technologies Says Invited To Join Alliance For Artificial Intelligence In Healthcare Benzinga

Apr 8, 2021

12:38PM EDT Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC Benzinga

document.getElementById("nPtn1d").onerror = function(){this.style.display='none';}; .dark-mode .tzlVkK{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .tzlVkK{ color: #333333; background-color: white; border: 2px solid #333333; }GSKGSK plcstock NYSE ADR

GSK
GSK plc
stock NYSE ADR